Albany Molecular Research Top Insiders

Albany Molecular Management Team Effectiveness

The company has return on total asset (ROA) of (0.0657) % which means that it has lost $0.0657 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (22.1137) %, meaning that it created substantial loss on money invested by shareholders. Albany Molecular's management efficiency ratios could be used to measure how well Albany Molecular manages its routine affairs as well as how well it operates its assets and liabilities. The company has Profit Margin (PM) of (11.94) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.87 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.87.

Albany Molecular Notable Stakeholders

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

If you are still planning to invest in Albany Molecular Research check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Albany Molecular's history and understand the potential risks before investing.